Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Reductive Carboxylation of Glutamine as a Potential Target in AML

News

January 16, 2024
PRESS RELEASE: On December 1, 2023, a new editorial was published in Oncotarget, entitled, “Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia.” continue reading »

How Osteopontin Stimulates Mitochondrial Biogenesis and Cancer Metastasis

Oncotarget

January 11, 2024
In this new study, researchers investigated the role of Osteopontin splice variants in cancer metastasis. continue reading »

One More Step Toward Treatment of PARP Inhibitor-resistant Ovarian Cancers

News

January 10, 2024
PRESS RELEASE: On December 22, 2023, a new editorial was published in Oncotarget, entitled, “One more step toward treatment of PARP inhibitor-resistant ovarian cancers.” continue reading »

Transformation-associated Recombination (TAR) Cloning and Its Applications

News

January 8, 2024
PRESS RELEASE: On December 22, 2023, a new review was published in Oncotarget, entitled, “Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine.” continue reading »

Therapeutically Harnessing Cancer Stem Cell-derived Exosomes

News

January 3, 2024
PRESS RELEASE: On December 20, 2023, a new editorial was published in Oncotarget: “Therapeutically harnessing cancer stem cell-derived exosomes.” continue reading »